Huntington Disease

Huntington Disease (HD) is a rare, progressive neurodegenerative disorder characterized by involuntary motor movements (chorea), cognitive decline, and psychiatric disturbances. It is an autosomal dominant condition resulting from a mutation in the HTT gene.

HD is caused by an expanded CAG trinucleotide repeat in the HTT gene on chromosome 4, which encodes the huntingtin protein. The mutation leads to toxic gain-of-function and loss of neuroprotective function. There are no known lifestyle triggers; it is strictly hereditary.

The expanded huntingtin protein aggregates in neurons, particularly within the striatum (caudate and putamen). This leads to the selective death of medium spiny neurons, disrupting motor and cognitive loops. Resultant striatal atrophy causes an imbalance in basal ganglia signaling.

Prevalence ranges from 5 to 10 per 100,000 individuals in populations of European descent. Onset typically occurs between ages 30 and

1. Gender distribution is equal.

• Family history of HD.
• Inheritance of an expanded CAG repeat (>36 repeats).

A. Early Symptoms

• Irritability, depression, mild personality changes, minor coordination issues. B. Common Symptoms


• Chorea (jerky, involuntary movements), motor impersistence, dysarthria, executive dysfunction. C. Advanced Symptoms


• Severe motor impairment, dysphagia, weight loss, total dependence, loss of speech. D. Emergency Symptoms


• Aspiration pneumonia, severe dysphagia, suicidal ideation, status choreaticus.

• Inspection: Chorea, tics, dystonic posturing, saccadic eye movement abnormalities.
• Auscultation: Often unremarkable unless pulmonary complications (aspiration) are present.

A. Clinical Assessment: Unified Huntington's Disease Rating Scale (UHDRS).
B. Laboratory Testing: Molecular genetic testing for *HTT

• CAG expansion.

Test Name: Molecular Genetic Test
Type: Blood Test
Purpose: Identify CAG repeat length.
Expected Findings: >36 CAG repeats.
Interpretation: Confirms HD; longer repeats correlate with earlier onset.

• MRI: Reveals caudate atrophy, ventricular enlargement (ex-vacuo). Essential for ruling out structural causes of chorea.

• Wilson disease: Checked via ceruloplasmin.
• Sydenham chorea: Associated with rheumatic fever.
• Spinocerebellar ataxias: Differentiated by genetic panel.

Aspiration pneumonia, pressure ulcers, depression, suicide, cachexia.

A. Lifestyle Modifications: Nutritional support for weight gain.
B. Preventive Measures: Genetic counseling.
C. Medical Treatment: - VMAT2 Inhibitors (Tetrabenazine, Deutetrabenazine) for chorea.

• Antipsychotics (Risperidone, Olanzapine) for behavioral issues.

Progressive, fatal within 15–20 years post-diagnosis. Death typically results from respiratory complications.

Genetic counseling for at-risk families; preimplantation genetic diagnosis (PGD).

The following homeopathic remedies have been historically indicated for symptoms associated with Huntington Disease. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Huntington Disease.